An Overview of Murine High Fat Diet as a Model for Type 2 Diabetes Mellitus

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Heydemann, Ahlke ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Center for Cardiovascular Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ADIPOSE TISSUE; ANIMAL MODEL; AUTOPHAGY; CLINICAL PROTOCOL; HEART; INFLAMMATION; LIPID DIET; LIPOTOXICITY; LIVER; METABOLIC PARAMETERS; MITOCHONDRION; MOUSE; MURINE MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS; PATHOGENESIS; REVIEW; SKELETAL MUSCLE; ANIMAL; DIABETIC CARDIOMYOPATHY; DISEASE MODEL; INBRED MOUSE STRAIN; METHODOLOGY; PRECLINICAL STUDY;

ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC CARDIOMYOPATHIES; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; MICE; MICE, INBRED STRAINS; RESEARCH DESIGN;

EID: 84986275931     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/2902351     Document Type: Review

References (112)

1. G. M. Reaven, "The insulin resistance syndrome: definition and dietary approaches to treatment," Annual Review of Nutrition, vol. 25, pp. 391-406, 2005.
2. L. A. Katunga, P. Gudimella, J. T. Efird et al., "Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy," Molecular Metabolism, vol. 4, no. 6, pp. 493-506, 2015.
3. I. Raz, R. Eldor, S. Cernea, and E. Shafrir, "Diabetes: insulin resistance and derangements in lipidmetabolism. Cure through intervention in fat transport and storage," Diabetes/Metabolism Research and Reviews, vol. 21, no. 1, pp. 3-14, 2005.
4. H. Baribault, "Mousemodels of type II diabetesmellitus indrug discovery," Methods in Molecular Biology, vol. 602, pp. 135-155, 2010.
5. J. Fuentes-Antras, B. Picatoste, A. Gomez-Hernandez, J. Egido, J. Tunon, and O. Lorenzo, "Updating experimental models of diabetic cardiomyopathy," Journal of Diabetes Research, vol. 2015, Article ID 656795, 15 pages, 2015.
6. M. S. Islam and D. T. Loots, "Experimental rodent models of type 2 diabetes: a review,"Methods and Findings in Experimental and Clinical Pharmacology, vol. 31, no. 4, pp. 249-261, 2009.
7. L. Peltonen and V. A. McKusick, "Genomics and medicine: dissecting human disease in the postgenomic era," Science, vol. 291, no. 5507, pp. 1224-1229, 2001.
8. A. Dogan, P. Lasch, C. Neuschl et al., "ATR-FTIR spectroscopy reveals genomic loci regulating the tissue response in high fat diet fed BXD recombinant inbred mouse strains," BMC Genomics, vol. 14, no. 1, article 386, 2013.
9. M. Kahle,M. Horsch, B. Fridrich et al., "Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis," Molecular Metabolism, vol. 2, no. 4, pp. 435-446, 2013.
10. E. K. Sims, M. Hatanaka, D. L. Morris et al., "Divergent compensatory responses to high-fat diet between C57BL6/J and C57BLKS/J inbred mouse strains," American Journal of Physiology-Endocrinology andMetabolism, vol. 305, no. 12, pp. E1495-E1511, 2013.
11. M. Kobayashi, T. Ohno, K. Ihara et al., "Searching for genomic region of high-fat diet-induced type 2 diabetes in mouse chromosome 2 by analysis of congenic strains," PLoS ONE, vol. 9, no. 5, Article IDe96271, 2014.
12. A. J. Mull, T. K. Berhanu, N. W. Roberts, and A. Heydemann, "The Murphy Roths Large (MRL) mouse strain is naturally resistant to high fat diet-induced hyperglycemia," Metabolism: Clinical and Experimental, vol. 63, no. 12, pp. 1577-1586, 2014.
13. D. A. Fontaine andD. B. Davis, "Attention to background strain is essential for metabolic research: c57bl/6 and the international knockoutmouse consortium," Diabetes, vol. 65, no. 1, pp. 25-33, 2015.
14. I. Abdesselam, P. Pepino, T. Troalen et al., "Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance," Journal of Cardiovascular Magnetic Resonance, vol. 17, article 95, 2015.
15. S. Carbone, A. G. Mauro, E. Mezzaroma et al., "A high-sugar and high-fat diet impairs cardiac systolic and diastolic function in mice," International Journal of Cardiology, vol. 198, pp. 66-69, 2015.
16. N. W. Roberts, M. González-Vega, T. K. Berhanu, A. Mull, J. Garcá, and A. Heydemann, "Successful metabolic adaptations leading to the prevention of high fat diet-induced murine cardiac remodeling," Cardiovascular Diabetology, vol. 14, no. 1, article 127, 2015.
17. J. Villarroya, I. Redondo-Angulo, R. Iglesias, M. Giralt, F. Villarroya, and A. Planavila, "Sirt1 mediates the effects of a short-term high-fat diet on the heart," Journal of Nutritional Biochemistry, vol. 26, no. 11, pp. 1328-1337, 2015.
18. S. D. Calligaris, M. Lecanda, F. Solis et al., "Mice longterm high-fat diet feeding recapitulates human cardiovascular alterations: an animalmodel to study the early phases of diabetic cardiomyopathy," PLoS ONE, vol. 8, no. 4, Article ID e60931, 2013.
19. R. E. Brainard, L. J. Watson, A. M. DeMartino et al., "High fat feeding in mice is insufficient to induce cardiac dysfunction and does not exacerbate heart failure," PLoS ONE, vol. 8, no. 12, Article ID e83174, 2013.
20. M. Lazo and J. M. Clark, "The epidemiology of nonalcoholic fatty liver disease: a global perspective," Seminars in Liver Disease, vol. 28, no. 4, pp. 339-350, 2008.
21. A. Nakamura and Y. Terauchi, "Lessons from mouse models of high-fat diet-induced NAFLD," International Journal of Molecular Sciences, vol. 14, no. 11, pp. 21240-21257, 2013.
22. R. Cancello and K. Clément, "Is obesity an inflammatory illness Role of low-grade inflammation and macrophage infiltration in human white adipose tissue," BJOG: An International Journal of Obstetrics and Gynaecology, vol. 113, no. 10, pp. 1141-1147, 2006.
23. M. F. Gregor and G. S. Hotamisligil, "Inflammatory mechanisms in obesity," Annual Review of Immunology, vol. 29, pp. 415-445, 2011.
24. Z. Hu, H. Wang, I. H. Lee et al., "PTEN inhibition improves muscle regeneration in mice fed a high-fat diet," Diabetes, vol. 59, no. 6, pp. 1312-1320, 2010.
25. O. Seitz, C. Schürmann, N. Hermes et al., "Wound healing in mice with high-fat diet-or ob gene-induced diabetesobesity syndromes: a comparative study," ExperimentalDiabetes Research, vol. 2010,Article ID 476969, 15 pages, 2010.
26. E. Shankar, N. Bhaskaran, G. T. MacLennan, G. Liu, F. Daneshgari, and S. Gupta, "Inflammatory signaling involved in high-fat diet induced prostate diseases," Journal of Urology and Research, vol. 2, no. 1, Article ID1018, 2015.
27. N. M. Delzenne, P. D. Cani, A. Everard, A. M. Neyrinck, and L. B. Bindels, "Gut microorganisms as promising targets for the management of type 2 diabetes," Diabetologia, vol. 58, no. 10, pp. 2206-2217, 2015.
28. E. A. Murphy, K. T. Velazquez, and K. M. Herbert, "Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk," Current Opinion in Clinical Nutrition and Metabolic Care, vol. 18, no. 5, pp. 515-520, 2015.
29. D. P. Singh, P. Khare, J. Zhu et al., "A novel cobiotic-based preventive approach against high-fat diet-induced adiposity, nonalcoholic fatty liver and gut derangement in mice," International Journal of Obesity, vol. 40, pp. 487-496, 2016.
30. J. P. Kesby, J. J. Kim, M. Scadeng et al., "Spatial cognition in adult and aged mice exposed to high-fat diet," PLoS ONE, vol. 10, no. 10, Article ID e0140034, 2015.
31. D. Nuzzo, P. Picone, S. Baldassano et al., "Insulin resistance as commonmolecular denominator linking obesity to Alzheimer's disease," Current Alzheimer Research, vol. 12, no. 8, pp. 723-735, 2015.
32. V. Kesherwani, V. Chavali, B. T. Hackfort, S. C. Tyagi, and P. K. Mishra, "Exercise ameliorates high fat diet induced cardiac dysfunction by increasing interleukin 10," Frontiers in Physiology, vol. 6, article 124, 2015.
33. L. A. Brown, D. E. Lee, J. F. Patton et al., "Diet-induced obesity alters anabolic signalling in mice at the onset of skeletal muscle regeneration," Acta Physiologica, vol. 215, no. 1, pp. 46-57, 2015.
34. K. A. Baltgalvis, K. White, W. Li et al., "Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice," American Journal of Physiology-Heart and Circulatory Physiology, vol. 306, no. 8, pp. H1128-H1145, 2014.
35. D. Akhmedov and R. Berdeaux, "The effects of obesity on skeletal muscle regeneration," Frontiers in Physiology, vol. 4, article 371, 2013.
36. M.-H. Nguyen, M. Cheng, and T. J. Koh, "Impaired muscle regeneration in Ob/ob and Db/db mice," TheScientificWorld-Journal, vol. 11, pp. 1525-1535, 2011.
37. J. V. Neel, "Diabetes mellitus: a 'thrifty' genotype rendered detrimental by 'progress'" The American Journal of Human Genetics, vol. 14, pp. 353-362, 1962.
38. J. R. Speakman and K. R. Westerterp, "A mathematical model of weight loss under total starvation: evidence against the thriftygene hypothesis," Disease Models and Mechanisms, vol. 6, no. 1, pp. 236-251, 2013.
39. Q. Ayub, L. Moutsianas, Y. Chen et al., "Revisiting the thrifty gene hypothesis via 65 loci associated with susceptibility to type 2 diabetes,"The American Journal of Human Genetics, vol. 94, no. 2, pp. 176-185, 2014.
40. X.-H. Koh, X. Liu, and Y.-Y. Teo, "Can evidence from genomewide association studies and positive natural selection surveys be used to evaluate the thrifty gene hypothesis in East Asians" PLoS ONE, vol. 9, no. 10, Article IDA1833, 2014.
41. H. Taegtmeyer, C. Beauloye,R. Harmancey, andL. Hue, "Insulin resistance protects the heart from fuel overload in dysregulated metabolic states," American Journal of Physiology-Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1693-H1697, 2013.
42. S. E. Nissen and K. Wolski, "Effect of rosiglitazone on the risk ofmyocardial infarction and death fromcardiovascular causes," The New England Journal ofMedicine, vol. 356, no. 24, pp. 2457-2471, 2007.
43. C. Ding, J. Guo, andZ. Su, "The statusof researchintoresistance to diet-induced obesity," Hormone and Metabolic Research, vol. 47, no. 6, pp. 404-410, 2015.
44. H.-Y. Lee, K.-H. Jeong, and C. S. Choi, "In-depth metabolic phenotyping of genetically engineered mousemodels in obesity and diabetes," Mammalian Genome, vol. 25, no. 9-10, pp. 508-521, 2014.
45. S. Guo, "Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms," Journal of Endocrinology, vol. 220, no. 2, pp. T1-T23, 2014.
46. A. E. Bunner, P. C. Chandrasekera, and N. D. Barnard, "Knockout mouse models of insulin signaling: relevance past and future," World Journal of Diabetes, vol. 5, no. 2,pp. 146-159, 2014.
47. M. I. McCarthy, "Genomics, type 2 diabetes, and obesity," The New England Journal of Medicine, vol. 363, no. 24, pp. 2339-2350, 2010.
48. N. Jovicic, I. Jeftic, I. Jovanovic et al., "Differential immunometabolic phenotype inTh1 and Th2 dominant mouse strains in response to high-fat feeding," PLoS ONE, vol. 10,no. 7, Article ID e0134089, 2015.
49. Y. Xue, J. Li, L. Yan, L. Lu, and F.-F. Liao, "Genetic variability to diet-induced hippocampal dysfunction in BXD recombinant inbred (RI)mouse strains," Behavioural Brain Research, vol. 292, pp. 83-94, 2015.
50. R. S. Surwit, M. N. Feinglos, J. Rodin et al., "Differential effects of fat and sucrose on the development of obesity and diabetes in C57BL/6J and A J mice," Metabolism, vol. 44, no. 5, pp. 645-651, 1995.
51. S. Andrikopoulos, A. R. Blair, N. Deluca, B. C. Fam, and J. Proietto, "Evaluating the glucose tolerance test in mice," American Journal of Physiology-Endocrinology andMetabolism, vol. 295, no. 6, pp. E1323-E1332, 2008.
52. Y. Ikeda, T. Suehiro, T. Nakamura, Y. Kumon, and K. Hashimoto, "Clinical significance of the insulin resistance index as assessed by homeostasis model assessment," Endocrine Journal, vol. 48, no. 1, pp. 81-86, 2001.
53. C. S. Choi, D. B. Savage, L. Abu-Elheiga et al., "Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fatmass, and improves insulin sensitivity," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 42, pp. 16480-16485, 2007.
54. Z. Zhang, S. Wang, S. Zhou et al., "Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway," Journal of Molecular and Cellular Cardiology, vol. 77, pp. 42-52, 2014.
55. M. V. Cannon, H. H. W. Silljé, J. W. A. Sijbesma et al., "LXR improves myocardial glucose tolerance and reduces cardiac hypertrophy in a mouse model of obesity-induced type 2 diabetes," Diabetologia, vol. 59, no. 3, pp. 634-643, 2016.
56. K. J. Strissel, Z. Stancheva, H. Miyoshi et al., "Adipocyte death, adipose tissue remodeling, and obesity complications," Diabetes, vol. 56, no. 12, pp. 2910-2918, 2007.
57. K. Tajima, A. Nakamura, J. Shirakawa et al., "Metformin prevents liver tumorigenesis induced by high-fat diet inC57Bl/6 mice," American Journal of Physiology-Endocrinology and Metabolism, vol. 305, no. 8, pp. E987-E998, 2013.
58. M. Ganz, T. N. Bukong, T. Csak et al., "Progression of nonalcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice," Journal of Translational Medicine, vol. 13, no. 1, article 193, 2015.
59. C. X. Fang, F. Dong, D. P. Thomas, H. Ma, L. He, and J. Ren, "Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription," American Journal of Physiology-Heart and Circulatory Physiology, vol. 295, no. 3, pp. H1206-H1215, 2008.
60. R. E. Mosser, M. F. Maulis, V. S. Moullé et al., "High-fat dietinduced-cell proliferation occurs prior to insulin resistance in C57Bl/6J male mice," American Journal of Physiology-Endocrinology and Metabolism, vol. 308, no. 7, pp. E573-E582, 2015.
61. G. V. Asha, R. G. Reddy, M. Mahesh, A. Vajreswari, and S. M. Jeyakumar, "Male mice are susceptible to high fat diet-induced hyperglycaemia and display increased circulatory retinol binding protein 4 (RBP4) levels and its expression in visceral adipose depots," Archives of Physiology and Biochemistry, vol. 122, no. 1, pp. 19-26, 2016.
62. Y. Macotela, J. Boucher, T. T. Tran, and C. R. Kahn, "Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism," Diabetes, vol. 58, no. 4, pp. 803-812, 2009.
63. E. Morselli, A. Criollo, C. Rodriguez-Navas, and D. J. Clegg, "Chronic high fat diet consumption impairs metabolic health of male mice," Inflammation and Cell Signaling, vol. 1, no. 6, p. e561, 2014.
64. M. L. Grundleger, V. Y. Godbole, and S. W. Thenen, "Agedependent development of insulin resistance of soleus muscle in genetically obese (ob/ob) mice," The American Journal of Physiology, vol. 239, no. 5, pp. E363-371, 1980.
65. M. Rossmeisl, J. S. Rim, R. A. Koza, and L. P. Kozak, "Variation in type 2 diabetes-related traits in mouse strains susceptible to diet-induced obesity," Diabetes, vol. 52, no. 8, pp. 1958-1966, 2003.
66. E. D. Berglund, C. Y. Li, G. Poffenberger et al., "Glucose metabolism in vivo in four commonly used inbred mouse strains," Diabetes, vol. 57, no. 7, pp. 1790-1799, 2008.
67. H. C. Freeman, A. Hugill, N. T. Dear, F. M. Ashcroft, and R. D. Cox, "Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice," Diabetes, vol. 55, no. 7, pp. 2153-2156, 2006.
68. J. L. Peirce, L. Lu, J. Gu, L. M. Silver, and R. W. Williams, "Anew set of BXD recombinant inbred lines from advanced intercross populations in mice," BMC Genetics, vol. 5, article 7, 2004.
69. W. C. Stanley, E. R. Dabkowski, R. F. Ribeiro, and K. A. O'Connell, "Dietary fat and heart failure: moving from lipotoxicity to lipoprotection," Circulation Research, vol. 110, no. 5, pp. 764-776, 2012.
70. N. Hariri, R. Gougeon, and L. Thibault, "A highly saturated fatrich diet is more obesogenic than diets with lower saturated fat content," Nutrition Research, vol. 30, no. 9, pp. 632-643, 2010.
71. M. Takahashi, S. Ikemoto, and O. Ezaki, "Effect of the fat/carbohydrate ratio in the diet on obesity and oral glucose tolerance in C57BL/6J mice," Journal of Nutritional Science and Vitaminology, vol. 45, no. 5, pp. 583-593, 1999.
72. T. U. Maioli, J. L. Goncalves,M. C. G. Miranda et al., "High sugar and butter (HSB) diet induces obesity and metabolic syndrome with decrease in regulatory T cells in adipose tissue of mice," Inflammation Research, vol. 65, no. 2, pp. 169-178, 2016.
73. J. Luo, J. Quan, J. Tsai et al., "Nongenetic mouse models of noninsulin-dependent diabetes mellitus," Metabolism: Clinical and Experimental, vol. 47, no. 6, pp. 663-668, 1998.
74. J. Cai, S. Lu, Z. Yao et al., "Glibenclamide attenuates myocardial injury by lipopolysaccharides in streptozotocin-induced diabetic mice," Cardiovascular Diabetology, vol. 13,no. 1, article 106, 2014.
75. K. A. Krawczewski Carhuatanta, G. Demuro, M. H. Tschöp, P. T. Pfluger, S. C. Benoit, and S. Obici, "Voluntary exercise improves high-fat diet-induced leptin resistance independent of adiposity," Endocrinology, vol. 152, no. 7, pp. 2655-2664, 2011.
76. Q. Wang, X. D. Perrard, J. L. Perrard et al., "Differential effect of weight loss with low-fat diet or high-fat diet restriction on inflammation in the liver and adipose tissue of mice with dietinduced obesity," Atherosclerosis, vol. 219, no. 1, pp. 100-108, 2011.
77. F. Q. Nuttall and M. C. Gannon, "Sucrose and disease," Diabetes Care, vol. 4, no. 2, pp. 305-310, 1981.
78. D. Mishmar, E. Ruiz-Pesini, P. Golik et al., "Natural selection shaped regional mtDNA variation in humans," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 1, pp. 171-176, 2003.
79. N. Apaijai, H. Pintana, S. C. Chattipakorn, andN. Chattipakorn, "Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats," British Journal of Pharmacology, vol. 169, no. 5, pp. 1048-1057, 2013.
80. N. S. Kalupahana, N. Moustaid-Moussa, and K. J. Claycombe, "Immunity as a link between obesity and insulin resistance," Molecular Aspects of Medicine, vol. 33, no. 1, pp. 26-34, 2012.
81. G. R. Romeo, J. Lee, and S. E. Shoelson, "Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1771-1776, 2012.
82. B. D. Henriksbo, T. C. Lau, J. F. Cavallari et al., "Fluvastatin causes NLRP3 inflammasome-mediated adipose insulin resistance," Diabetes, vol. 63, no. 11, pp. 3742-3747, 2014.
83. J. D. Schilling and D. L. Mann, "Diabetic cardiomyopathy: bench to bedside," Heart Failure Clinics, vol. 8, no. 4, pp. 619-631, 2012.
84. R. Stienstra, S. Mandard, D. Patsouris, C. Maass, S. Kersten, and M. Müller, "Peroxisome proliferator-activated receptor protects against obesity-induced hepatic inflammation," Endocrinology, vol. 148, no. 6, pp. 2753-2763, 2007.
85. R. H. Ritchie and L. M. D. Delbridge, "Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect" Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 1-2, pp. 159-166, 2006.
86. E. Di Marco, J. C. Jha, A. Sharma, J. L. Wilkinson-Berka, K. A. Jandeleit-Dahm, and J. B. DeHaan, "Are reactive oxygen species still the basis for diabetic complications" Clinical Science, vol. 129, no. 2, pp. 199-216, 2016.
87. T. Yu, S.-S. Sheu, J. L. Robotham, and Y. Yoon, "Mitochondrial fission mediates high glucose-induced cell death through elevated production of reactive oxygen species," Cardiovascular Research, vol. 79, no. 2, pp. 341-351, 2008.
88. T. Watanabe, M. Saotome, M. Nobuhara et al., "Roles of mitochondrial fragmentation and reactive oxygen species in mitochondrial dysfunction and myocardial insulin resistance," Experimental Cell Research, vol. 323, no. 2, pp. 314-325, 2014.
89. H.-C. Hsu, C.-Y. Chen, B.-C. Lee, and M.-F. Chen, "Highfat diet induces cardiomyocyte apoptosis via the inhibition of autophagy," European Journal of Nutrition, 2015.
90. K. Liu, E. Zhao,G. Ilyas et al., "Impairedmacrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization," Autophagy, vol. 11, no. 2, pp. 271-284, 2015.
91. L. V. Yuzefovych, S. I. Musiyenko, G. L. Wilson, and L. I. Rachek, "Mitochondrial DNA damage and dysfunction, and oxidative stress are associated with endoplasmic reticulum stress, protein degradation and apoptosis in high fat diet-induced insulin resistance mice," PLoSONE, vol. 8, no. 1,Article IDe54059,2013.
92. S. Sciarretta, M. Volpe, and J. Sadoshima, "Is reactivation of autophagy a possible therapeutic solution for obesity and metabolic syndrome" Autophagy, vol. 8, no. 8, pp. 1252-1254, 2012.
93. Y. Liu, R. Palanivel, E. Rai et al., "Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high-fat diet feeding in mice," Diabetes, vol. 64, no. 1, pp. 36-48, 2015.
94. D. Montaigne, X. Marechal, A. Coisne et al., "Myocardial contractile dysfunction is associated with impaired mitochondrial function and dynamics in type 2 diabetic but not in obese patients," Circulation, vol. 130, no. 7, pp. 554-564, 2014.
95. F. Westermeier, M. Navarro-Marquez, C. López-Crisosto et al., "Defective insulin signaling and mitochondrial dynamics in diabetic cardiomyopathy," Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1853, no. 5, pp. 1113-1118, 2015.
96. V. Parra, H. E. Verdejo, M. Iglewski et al., "Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFB-Opa-1 signaling pathway," Diabetes, vol. 63, no. 1, pp. 75-88, 2014.
97. S. Gundewar, J. W. Calvert, S. Jha et al., "Activation of AMPactivated protein kinase by metformin improves left ventricular function and survival in heart failure," Circulation Research, vol. 104, no. 3, pp. 403-411, 2009.
98. E. A. Bradley, L. Zhang, A. J. Genders, S. M. Richards, S. Rattigan, and M. A. Keske, "Enhancement of insulin-mediated rat muscle glucose uptake and microvascular perfusion by 5-aminoimidazole-4-carboxamide-1-d-ribofuranoside," Cardiovascular Diabetology, vol. 14, no. 1, article 91, 2015.
99. B.-C. Lee and J. Lee, "Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance," Biochimica et Biophysica Acta-Molecular Basis of Disease, vol. 1842, no. 3, pp. 446-462, 2014.
100. K. I. Stanford, R. J. W. Middelbeek, K. L. Townsend et al., "Brown adipose tissue regulates glucose homeostasis and insulin sensitivity,"The Journal of Clinical Investigation, vol. 123, no. 1, pp. 215-223, 2013.
101. S. Virtue and A. Vidal-Puig, "Assessment of brown adipose tissue function," Frontiers in Physiology, vol. 4, article 128, 2013.
102. K. Majzner, K. Kochan, N. Kachamakova-Trojanowska, E. Maslak, S. Chlopicki, and M. Baranska, "Raman imaging providing insights into chemical composition of lipid droplets of different size and origin: in hepatocytes and endothelium," Analytical Chemistry, vol. 86, no. 13, pp. 6666-6674, 2014.
103. G. Kanuri and I. Bergheim, "In vitro and in vivomodels of nonalcoholic fatty liver disease (NAFLD)," International Journal of Molecular Sciences, vol. 14, no. 6, pp. 11963-11980, 2013.
104. A. Consoli, N. Nurjhan, F. Capani, and J. Gerich, "Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM," Diabetes, vol. 38, no. 5, pp. 550-557, 1989.
105. M. S. Brown and J. L. Goldstein, "Selective versus total insulin resistance: a pathogenic paradox," Cell Metabolism, vol. 7, no. 2, pp. 95-96, 2008.
106. P. K. Battiprolu,T. G. Gillette, Z. V. Wang, S. Lavandero, and J. A. Hill, "Diabetic cardiomyopathy: mechanisms and therapeutic targets," Drug Discovery Today: Disease Mechanisms, vol. 7, no. 2, pp. e135-e143, 2010.
107. P. K. Battiprolu, B. Hojayev, N. Jiang et al., "Metabolic stressinduced activation of FoxO1 triggers diabetic cardiomyopathy in mice," Journal of Clinical Investigation, vol. 122, no. 3, pp. 1109-1118, 2012.
108. R. H. Unger, "Lipotoxic diseases," Annual Review of Medicine, vol. 53, pp. 319-336, 2002.
109. T. F. Galvao, B. H. Brown, P. A. Hecker et al., "High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects," Cardiovascular Research, vol. 93, no. 1, pp. 24-32, 2012.
110. G. C. Fonarow, P. Srikanthan, M. R. Costanzo, G. B. Cintron, and M. Lopatin, "An obesity paradox in acute heart failure: analysis of bodymass index and inhospitalmortality for 108 927 patients in the Acute Decompensated Heart Failure National Registry,"AmericanHeart Journal, vol. 153, no. 1,pp. 74-81, 2007.
111. M. Poncelas, J. Inserte, U. Vilardosa et al., "Obesity induced by high fat diet attenuates postinfarct myocardial remodeling and dysfunction in adult B6D2F1 mice," Journal of Molecular and Cellular Cardiology, vol. 84, pp. 154-161, 2015.
112. Y. Zhou, S. Lin, L. Zhang, and Y. Li, "Resveratrol prevents renal lipotoxicity in high-fat diet-treated mouse model through regulating PPAR-pathway," Molecular and Cellular Biochemistry, vol. 411, no. 1-2, pp. 143-150, 2016.